Dana Rabinovich

Dana Rabinovich is the Co-Founder and CEO of OphtiMedRx, a pre-clinical drug development startup focused on developing molecular therapy for dry Age-related Macular Degeneration (AMD). Prior to this role, Dana was the owner of DR Biotech - Consulting and held positions such as Project Leader at Mor Research Applications, VP R&D at OmeCare, and Senior Project Manager at Salzman Group. With a background in Molecular Neuroscience (Ph.D.) and Molecular Genetics (M.Sc.), Dana has also served as a Research Director at GGA - Galil Genetic Analysis and as a Postdoctoral Fellow at the Weizmann Institute of Science. Additionally, Dana has experience mentoring students at the Davidson Institute of Science Education.